Medgold Closes Acquisition of Klondike Gold's Portuguese Assets
31 1월 2014 - 2:00AM
Marketwired
Medgold Closes Acquisition of Klondike Gold's Portuguese Assets
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan 30, 2014) -
Medgold Resources Corp. (TSX-VENTURE:MED), the European focused
gold exploration company, is pleased to announce that it has closed
the acquisition of Klondike Gold Corp's ("Klondike") Portuguese
exploration assets (see Medgold press release dated December 11,
2013). The portfolio is comprised of five gold exploration permits
covering 600 sq km in northern Portugal, primarily located along
the Valongo Belt, which has been identified as a major gold-bearing
district.
Dan James, the President of Medgold, said: "We're very happy to
announce the closing of the Klondike acquisition which puts Medgold
at the forefront of gold exploration in Portugal. The deal has
secured a major land position covering a series of excellent,
large-scale, exploration targets in the north of the country. We
now control most of the highly prospective Valongo Belt, including
the Castromil project, in addition to our existing Boticas and Vila
de Rei projects, which equates to a total land-holding of
approximately 1,000 sq km. Our objective now is to generate drill
targets for testing as soon as possible."
The Klondike Projects
The Klondike projects combine five exploration licences
(Balazar, Valongo, Legares, Castelo do Paiva and Ponte de Barca),
totaling 604 sq km, with four covering the majority of the Valongo
anticline, plus Ponte de Barca, which covers several orogenic gold
occurrences in the very north of Portugal. The Valongo anticline is
a large overturned fold hosting numerous gold occurrences, many of
which were exploited by the Romans. Recent interpretations clearly
demonstrate that mineralization within the Valongo Belt was
introduced by a series of faults and fractures, and is focused into
'saddle reefs' and en echelon vein arrays, commonly with
zones of massive sulphide and quartz veining in a number of
different lithologies.
The most advanced project is the Castromil project, located
within the Legares licence. Historical exploration, undertaken by
both Connary Minerals plc ("Connary") and previous explorers,
focused on near-surface high-grade mineralization, and included
multiple phases of shallow percussion and diamond drilling,
culminating in a 1997 mineral resource estimate (historical, see
below) of 2.42 Mt at 1.89 g/t Au measured and indicated for
approximately 145,000 oz Au. ("Class III feasibility study,
Castrolmil Gold Mine, Portugal, for Connary Minerals plc", ACA
Howe Mining & Metallurgy Ltd., October 1997; "the Connary
Report"). Recent work by the Company's adviser, Jim Mortensen,
clearly demonstrates that the mineralization is open at depth and
along strike in both directions, highlighting the potential for
additional discovery.
A qualified person has not done sufficient work to classify
the historical mineral resource given in the Connary Report as a
current mineral resource, and the Company is not treating the
historical mineral resource as current. Neither the qualified
person nor the Company has independently verified the information
contained in the Connary Report. The historical mineral resource
was prepared by ACA Howe Mining & Metallurgy Ltd. using a
geologically constrained block model, with block grades calculated
using an anisotropic inverse distance weighting method with an
elliptical search radius oriented down the plunge of interpreted
mineralized rock volumes. The qualified person has been unable to
verify whether the definitions of "measured" and "indicated" used
in the Connary Report in the context of its mineral resource
statement are equivalent to those set out in section 1.2 of
National Instrument 43-101. The mineral resource statement in the
Connary Report does not report the measured and indicated resource
categories separately, and reports no resources in the inferred
category. The definition of "Class III feasibility study" described
in the Connary Report does not correspond to the definition of
"feasibility study" as set out in section 1.4 of National
Instrument 43-101. The work described in the Connary Report appears
to the Company and its qualified person to have been performed to a
high technical standard and they consider it reliable, but it is
currently unknown what work would be required to upgrade or verify
the historical mineral resource as current, or if it is
possible.
The Ponte de Barca licence is located in northern Portugal and
approximately 75 km northeast from the city of Porto. The geology
and controls on mineralization are very similar to the Boticas
project, where high-grade mineralization is controlled by a series
of strike-extensive and high-angle tension veins. Klondike has
completed some limited rock-chip sampling, with 15 samples
collected, yielding results from trace to 14.8, 12.9 and 12.0 g/t
Au. The Company has not independently verified Klondike's
results.
Qualified Person
Mr. David Clark, M.Sc., P.Geo. (APEGBC), Consulting Geologist to
the Company, is a Qualified Person as defined by National
Instrument 43-101 - Standards of Disclosure for Mineral
Projects. Mr. Clark has approved the disclosure of technical
information contained in this news release.
About Medgold
Medgold is aiming to become the leading Mediterranean-focused
gold exploration and project development company, with an extensive
portfolio and pipeline of projects across Portugal, Italy and
Spain, targeting economically stressed, but politically stable
European countries that are seeking foreign investment to
invigorate the mining sector.
Additional information on Medgold can be found on the
Company's website at www.medgoldresources.com and by reviewing the
Company's page on SEDAR at www.sedar.com.
ON BEHALF OF THE BOARD
Daniel P. James, President & Director
Neither the TSX Venture Exchange nor the Investment Industry
Regulatory Organization of Canada accepts responsibility for the
adequacy or accuracy of this release.
Forward-looking statements
This press release may contain forward-looking statements
including, but not limited to, comments regarding the timing and
content of upcoming work programs, geological interpretations,
receipt of property titles, potential mineral recovery processes,
and other related matters. Forward-looking statements address
future events and conditions and therefore involve inherent risks
and uncertainties. Medgold's projects in Europe are at an early
stage and all estimates and projections are based on limited, and
possibly incomplete, data. More work is required before the
mineralization and the projects' economic aspects can be
confidently modelled. Actual results may differ materially from
those currently anticipated in this news release. No representation
or prediction is intended as to the results of future work, nor can
there be any promise that the estimates and projections herein will
be sustained in future work or that the projects will otherwise
prove to be economic.
Investor RelationsRalph Rushton (Vancouver)+1
604-801-5432ralphr@goldgroup.comPresidentDan James (UK and
Portugal)+44 (0) 7972 579188dj@medgoldresources.com
Medgold Resources (TSXV:MED)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Medgold Resources (TSXV:MED)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025